Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001764013-24-000018
Filing Date
2024-01-29
Accepted
2024-01-29 16:12:54
Documents
1
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1706562754.html 4  
1 FORM 4 wk-form4_1706562754.xml 4 6119
  Complete submission text file 0001764013-24-000018.txt   7648
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address
Levine Mark S. (Reporting) CIK: 0001617236 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 24573790

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)